Benzothiazol-bromo-phenyl-oxadiazol-sulfanyl-acetamide-cpd11n
IC50 AChE 0.088 +/- 0.03 microM
General
Type : Benzothiazol, Oxadiazol, Sulfur Compound
Chemical_Nomenclature : N-(6-bromo-1,3-benzothiazol-2-yl)-2-[(5-phenyl-1,3,4-oxadiazol-2-yl)sulfanyl]acetamide
Canonical SMILES : C1=CC=C(C=C1)C2=NN=C(O2)SCC(=O)NC3=NC4=C(S3)C=C(C=C4)Br
InChI : InChI=1S\/C17H11BrN4O2S2\/c18-11-6-7-12-13(8-11)26-16(19-12)20-14(23)9-25-17-22-21-15(24-17)10-4-2-1-3-5-10\/h1-8H,9H2,(H,19,20,23)
InChIKey : WQQZGBYIXCJGOE-UHFFFAOYSA-N
Other name(s) : Compound 11n
MW : 447.3
Formula : C17H11BrN4O2S2
CAS_number :
PubChem : 3974901
UniChem : WQQZGBYIXCJGOE-UHFFFAOYSA-N
Target
Families : Benzothiazol-bromo-phenyl-oxadiazol-sulfanyl-acetamide-cpd11n ligand of proteins in family
ACHE
Protein :
human-ACHE
References (1)
| Title : Computational drug design, synthesis, acetylcholinesterase inhibition and kinetic evaluation of novel benzothiazole-thiadiazole\/oxadiazole derivatives - Ambatwar_2026_Future.Med.Chem__1 |
| Author(s) : Ambatwar R , Singh P , Ghosh S , Chandrakar L , Datusalia AK , Khatik GL |
| Ref : Future Med Chem , :1 , 2026 |
| Abstract : |
| PubMedSearch : Ambatwar_2026_Future.Med.Chem__1 |
| PubMedID: 42836360 |